HK Stock MarketDetailed Quotes
02196 FOSUN PHARMA
- 12.640
- 0.0000.00%
Pre-Opening Auction May 3 09:00 CST
33.78BMarket Cap15.16P/E (TTM)
0.000High0.000Low0Volume0.000Open12.640Pre Close0.00Turnover0.00%Turnover Ratio12.77P/E (Static)2.67BShares22.49052wk High0.66P/B6.98BFloat Cap11.32052wk Low0.46Dividend TTM551.94MShs Float80.880Historical High0.460Dividend LFY0.00%Amplitude6.197Historical Low--Avg Price500Lot Size3.64%Div YieldTTM3.64%Div Yield LFY
FOSUN PHARMA Key Stats
All
YOY
| (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -28.46%3.28B | ---- | ---- | ---- | -24.20%4.58B | ---- | ---- | ---- | 29.18%6.04B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -0.37%-155.58M | ---- | ---- | ---- | -67.90%-155.01M | ---- | ---- | ---- | ---92.32M |
| Dividend (income)- adjustment | ---- | 2.74%-61.44M | ---- | ---- | ---- | -31.88%-63.17M | ---- | ---- | ---- | -76.52%-47.9M |
| Attributable subsidiary (profit) loss | ---- | -19.06%-2.18B | ---- | ---- | ---- | -2.57%-1.84B | ---- | ---- | ---- | -13.21%-1.79B |
| Impairment and provisions: | --0 | 4.09%351.67M | --0 | --0 | --0 | -62.62%337.86M | --0 | --0 | --0 | 257.14%903.89M |
| -Impairment of property, plant and equipment (reversal) | ---- | -41.17%2.41M | ---- | ---- | ---- | --4.09M | ---- | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | 40.56%121.34M | ---- | ---- | ---- | 33.61%86.33M | ---- | ---- | ---- | 0.33%64.61M |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | 20.00%180M | ---- | ---- | ---- | --150M |
| -Other impairments and provisions | ---- | 237.97%227.92M | ---- | ---- | ---- | -90.22%67.44M | ---- | ---- | ---- | 265.30%689.28M |
| Revaluation surplus: | --0 | -82.89%427.38M | --0 | --0 | --0 | 669.45%2.5B | --0 | --0 | --0 | 24.18%-438.73M |
| -Other fair value changes | ---- | -82.89%427.38M | ---- | ---- | ---- | 669.45%2.5B | ---- | ---- | ---- | 24.18%-438.73M |
| Asset sale loss (gain): | --0 | 51.15%-1.27B | --0 | --0 | --0 | 2.61%-2.6B | --0 | --0 | --0 | -296.77%-2.67B |
| -Loss (gain) from sale of subsidiary company | ---- | -99.27%-709.55M | ---- | ---- | ---- | 86.81%-356.08M | ---- | ---- | ---- | -1,082.18%-2.7B |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 99.52%-538K | ---- | ---- | ---- | -430.65%-111.28M | ---- | ---- | ---- | 665.08%33.66M |
| -Loss (gain) from selling other assets | ---- | 73.78%-558.49M | ---- | ---- | ---- | ---2.13B | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | --0 | 27.42%3.12B | --0 | --0 | --0 | 25.62%2.45B | --0 | --0 | --0 | 12.75%1.95B |
| -Depreciation | ---- | 21.56%1.84B | ---- | ---- | ---- | 9.39%1.51B | ---- | ---- | ---- | 13.81%1.38B |
| -Amortization of intangible assets | ---- | 36.86%1.28B | ---- | ---- | ---- | 65.08%937.2M | ---- | ---- | ---- | 10.26%567.71M |
| Financial expense | ---- | 37.46%1.32B | ---- | ---- | ---- | 17.17%963.81M | ---- | ---- | ---- | -6.63%822.54M |
| Special items | ---- | -17.43%35.62M | ---- | ---- | ---- | -32.83%43.14M | ---- | ---- | ---- | 31.96%64.23M |
| Operating profit before the change of operating capital | --0 | -21.80%4.86B | --0 | --0 | --0 | 31.05%6.22B | --0 | --0 | --0 | 0.35%4.75B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 76.65%-333.91M | ---- | ---- | ---- | -207.71%-1.43B | ---- | ---- | ---- | 62.92%-464.75M |
| Accounts receivable (increase)decrease | ---- | 124.25%396.15M | ---- | ---- | ---- | -4.74%-1.63B | ---- | ---- | ---- | -553.85%-1.56B |
| Accounts payable increase (decrease) | ---- | -178.65%-1.33B | ---- | ---- | ---- | -40.99%1.69B | ---- | ---- | ---- | 88.72%2.86B |
| prepayments (increase)decrease | ---- | 41.14%741.28M | ---- | ---- | ---- | 220.35%525.22M | ---- | ---- | ---- | 61.64%-436.41M |
| Cash from business operations | --0 | -12.10%4.31B | --0 | 6.04%2.33B | --0 | 2.44%4.91B | --0 | 5.05%2.2B | --0 | 34.52%4.79B |
| Other taxs | ---- | -30.40%-899.66M | ---- | -30.29%-523.11M | ---- | 19.12%-689.9M | ---- | -3.56%-401.48M | ---- | 13.11%-852.99M |
| Special items of business | ---- | 94.45%-25.77M | ---- | ---- | ---- | -29.71%-464.38M | ---- | ---- | ---- | -534.64%-358M |
| Net cash from operations | 5.05%917.31M | -19.05%3.41B | -21.70%2.46B | 0.63%1.81B | 2.06%873.24M | 7.10%4.22B | 4.24%3.14B | 5.39%1.8B | 16.13%855.61M | 52.64%3.94B |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | ---- | 7.42%770.73M | ---- | -7.59%81.22M | ---- | 8.34%717.5M | ---- | 27.08%87.89M | ---- | 15.60%662.25M |
| Loan receivable (increase) decrease | ---- | -133.84%-60.46M | ---- | -90.62%15.14M | ---- | 566.74%178.67M | ---- | --161.37M | ---- | --26.8M |
| Decrease in deposits (increase) | ---- | 158.90%650.97M | ---- | 204.67%1.37B | ---- | -164.68%-1.11B | ---- | -59.97%-1.31B | ---- | 62.05%-417.56M |
| Sale of fixed assets | -48.22%1.17M | -91.59%9.01M | -94.86%7.18M | -97.14%2.97M | -95.66%2.26M | 10.33%107.13M | 47.31%139.77M | 462.87%103.69M | 2,675.90%52.12M | 993.32%97.1M |
| Purchase of fixed assets | 26.34%-1.25B | 9.38%-5.34B | 5.78%-4.22B | -13.38%-2.94B | -13.61%-1.7B | -18.42%-5.89B | -27.83%-4.48B | -13.53%-2.6B | -17.55%-1.5B | -12.07%-4.97B |
| Sale of subsidiaries | --138.27M | -99.96%300K | ---- | ---- | ---- | -76.02%709.21M | 16.82%704.49M | 196.49%704.49M | --385.27M | 246.22%2.96B |
| Acquisition of subsidiaries | ---- | 4.62%-1.6B | 3.42%-1.15B | -96.64%-1.37B | 89.64%-47.59M | -0.86%-1.68B | -860.18%-1.19B | -475.15%-699.17M | -26,154.35%-459.45M | -185.13%-1.66B |
| Recovery of cash from investments | -96.09%19.4M | -51.44%1.86B | -51.40%971.68M | -54.36%573.4M | -55.54%496.38M | 1,518.84%3.83B | 106.84%2B | 1,339.41%1.26B | 128.81%1.12B | -62.05%236.65M |
| Cash on investment | 56.02%-37.18M | 69.58%-310.98M | 19.82%-691.32M | 18.45%-205.57M | 70.17%-84.55M | -17.88%-1.02B | -35.62%-862.2M | -31.46%-252.07M | -109.12%-283.4M | -34.57%-867.32M |
| Other items in the investment business | -104.86%-58.33M | 126.69%198.91M | 443.01%1.79B | 100.50%116.6M | 253.43%1.2B | 3.89%87.75M | -4,937.99%-522.14M | -89.55%58.15M | -19.90%-781.76M | --84.46M |
| Net cash from investment operations | -768.33%-1.19B | 6.02%-3.82B | 21.85%-3.28B | 4.96%-2.36B | 90.67%-137.18M | -5.35%-4.06B | -62.55%-4.2B | -1.45%-2.49B | 6.67%-1.47B | 18.03%-3.86B |
| Net cash before financing | -137.20%-273.82M | -363.83%-405.07M | 22.31%-822.65M | 19.60%-552.02M | 219.86%736.07M | 91.14%153.53M | -346.02%-1.06B | 7.61%-686.56M | 26.71%-614.12M | 103.78%80.33M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 16.06%7.99B | -22.79%23.18B | -27.11%18.05B | -23.55%13.66B | -8.31%6.88B | 2.70%30.02B | 16.52%24.77B | 25.53%17.87B | 6.71%7.51B | 62.62%29.23B |
| Refund | -22.00%-7.63B | 17.09%-21.79B | 25.19%-15.55B | 10.89%-11.51B | -27.70%-6.25B | 4.06%-26.28B | -4.57%-20.78B | -1.57%-12.92B | 11.07%-4.9B | -76.32%-27.39B |
| Interest paid - financing | ---- | -42.03%-1.33B | ---- | -39.47%-625.16M | ---- | -15.61%-937.34M | ---- | -6.83%-448.22M | ---- | -0.08%-810.8M |
| Dividends paid - financing | -5.84%-344.87M | 15.87%-1.33B | -1.38%-2.28B | 88.88%-156.73M | -41.13%-325.84M | -13.17%-1.58B | -21.81%-2.25B | -1,942.64%-1.41B | 23.32%-230.88M | -2.56%-1.4B |
| Absorb investment income | 562.89%114.18M | -37.11%362.92M | -99.04%43.94M | -41.43%265.32M | -27.45%17.23M | -52.10%577.04M | 476.81%4.58B | 80.23%453.03M | -85.42%23.74M | -3.47%1.2B |
| Issuance expenses and redemption of securities expenses | ---- | -99.82%7.91M | ---- | ---- | ---- | --4.51B | ---- | ---- | ---- | ---- |
| Other items of the financing business | 23.96%-29.61M | 76.91%-433.84M | 50.40%-662.17M | 78.90%-232.85M | 95.42%-38.94M | -13.64%-1.88B | -24.86%-1.34B | -117.17%-1.1B | -354.25%-849.55M | -122,571.04%-1.65B |
| Net cash from financing operations | -65.02%98.64M | -130.17%-1.34B | -107.97%-396.58M | -42.65%1.4B | -81.85%281.97M | 640.45%4.43B | 767.80%4.97B | 217.17%2.44B | 29.13%1.55B | -155.85%-819.41M |
| Effect of rate | 134.79%23.44M | -42.62%73.65M | -58.87%131.33M | -39.16%41.42M | -43.31%-67.37M | 195.27%128.34M | 521.01%319.32M | 165.92%68.08M | -266.37%-47.01M | 55.12%-134.71M |
| Net Cash | -115.96%-151.74M | -138.00%-1.74B | -125.70%-1.09B | -51.68%847.89M | 6.56%950.67M | 719.96%4.58B | 1,185.08%4.23B | 6,504.56%1.75B | 126.88%892.19M | -12.10%-739.08M |
| Begining period cash | -14.93%9.5B | 72.92%11.17B | 72.92%11.17B | 72.92%11.17B | 72.92%11.17B | -11.92%6.46B | -11.81%6.46B | -11.81%6.46B | -11.81%6.46B | -11.48%7.33B |
| Cash at the end | -22.85%9.35B | -14.93%9.5B | -5.71%10.08B | 45.60%12.06B | 64.87%12.12B | 72.92%11.17B | 54.20%10.69B | 14.27%8.28B | -4.74%7.35B | -11.81%6.46B |
| Cash balance analysis | ||||||||||
| Cash and cash equivalent balance | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young (Special General Partnership) | -- | -- | -- | Ernst & Young (Special General Partnership) | -- | -- | -- | Ernst & Young (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg